Related Experiment Video
Updated: Mar 5, 2026

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
PTPIP51 regulates mouse cardiac ischemia/reperfusion through mediating the mitochondria-SR junction
Xue Qiao1, Shi Jia1, Jingjing Ye1
1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing 100191, China.
Abstract:
Protein tyrosine phosphatase interacting protein 51 (PTPIP51) participates in multiple cellular processes, and dysfunction of PTPIP51 is implicated in diseases such as cancer and neurodegenerative disorders. However, there is no functional evidence showing the physiological or pathological roles of PTPIP51 in the heart. We have therefore investigated the role and mechanisms of PTPIP51 in regulating cardiac function. We found that PTPIP51 was markedly upregulated in ischemia/reperfusion heart. Upregulation of PTPIP51 by adenovirus-mediated overexpression markedly increased the contact of mitochondria-sarcoplasmic reticulum (SR), elevated mitochondrial Ca2+ uptake from SR release through mitochondrial Ca2+uniporter. Inhibition or knockdown of mitochondrial Ca2+uniporter reversed PTPIP51-mediated increase of mitochondrial Ca2+ and protected cardiomyocytes against PTPIP51-mediated apoptosis. More importantly, cardiac specific knockdown of PTPIP51 largely reduced myocardium infarction size and heart injury after ischemia/reperfusion. Our study defines a novel and essential function of PTPIP51 in the cardiac ischemia/reperfusion process by mediating mitochondria-SR contact. Downregulation of PTPIP51 improves heart function after ischemia/reperfusion injury, suggesting PTPIP51 as a therapeutic target for ischemic heart diseases.
Insights
Protein tyrosine phosphatase interacting protein 51 (PTPIP51) regulates heart function by increasing mitochondria-sarcoplasmic reticulum contact. Lowering PTPIP51 protects against ischemia/reperfusion injury, identifying it as a therapeutic target for heart disease.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Function
- Cellular Signaling
Background:
- Protein tyrosine phosphatase interacting protein 51 (PTPIP51) is involved in various cellular processes, with its dysfunction linked to cancer and neurodegenerative diseases.
- The specific roles of PTPIP51 in cardiac physiology and pathology remain largely unexplored.
Purpose of the Study:
- To investigate the function and underlying mechanisms of PTPIP51 in regulating cardiac function, particularly in the context of ischemia/reperfusion (I/R) injury.
- To determine if PTPIP51 plays a role in cardiac I/R injury and if it can be a therapeutic target.
Main Methods:
- Adenovirus-mediated overexpression of PTPIP51 in cardiomyocytes.
- Assessment of mitochondria-sarcoplasmic reticulum (SR) contact and mitochondrial calcium uptake.
- Knockdown of PTPIP51 in a cardiac-specific manner in vivo.
- Evaluation of myocardial infarction size and cardiac injury following I/R.
Main Results:
- PTPIP51 expression was significantly upregulated in I/R heart tissue.
- Overexpression of PTPIP51 enhanced mitochondria-SR contact and mitochondrial calcium uptake via the mitochondrial calcium uniporter.
- Cardiac-specific knockdown of PTPIP51 reduced infarct size and protected the heart against I/R injury.
- Inhibition of mitochondrial calcium uptake reversed PTPIP51-induced effects and protected against apoptosis.
Conclusions:
- PTPIP51 plays a critical role in cardiac I/R injury by modulating mitochondria-SR contact and calcium handling.
- Downregulation of PTPIP51 demonstrates a protective effect against I/R-induced heart damage.
- PTPIP51 represents a potential therapeutic target for treating ischemic heart diseases.
More Related Videos
13:42Multi-parameter Measurement of the Permeability Transition Pore Opening in Isolated Mouse Heart Mitochondria
Published on: September 7, 2012
07:14A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018